Company Filing History:
1 out of 2 
1 out of 3 
1 out of 1 Years Active: 2019-2025
Title: Catherine Hoofd: Innovator in Anti-TIGIT Antibodies
Introduction
Catherine Hoofd is a prominent inventor based in Gosselies, Belgium. She has made significant contributions to the field of immunotherapy, particularly through her work on anti-TIGIT antibodies. With a total of three patents to her name, her innovations are paving the way for new cancer treatments.
Latest Patents
Catherine's latest patents focus on anti-TIGIT antibodies and antigen binding fragments that inhibit TIGIT-mediated signaling. These patents detail methods for promoting T cell activity and treating cancer using these antibodies. The full patent texts provide comprehensive information on the combinations of these antibodies with additional therapeutic agents, as well as methods applicable to human subjects.
Career Highlights
Throughout her career, Catherine has worked with notable companies such as Iteos Therapeutics and Iteos Belgium. Her expertise in the development of therapeutic agents has positioned her as a key figure in the biotechnology sector.
Collaborations
Catherine has collaborated with esteemed colleagues, including Gregory Driessens and Anthony B Cooper. These partnerships have further enhanced her research and development efforts in the field of immunotherapy.
Conclusion
Catherine Hoofd's innovative work on anti-TIGIT antibodies represents a significant advancement in cancer treatment. Her contributions continue to influence the landscape of immunotherapy and offer hope for improved patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.